Dr. Jeff Kraakivk, MD
Claim this profileClinical Trials Jeff Kraakivk, MD is currently running
More about Jeff Kraakivk, MD
Clinical Trial Related
2 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 1 Active Clinical Trial
Treatments Jeff Kraakivk, MD has experience with
- Active Vibrotactile Coordinated Reset
- Sham Vibrotactile Coordinated Reset
Breakdown of trials Jeff Kraakivk, MD has run
Parkinson's Disease
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Jeff Kraakivk, MD specialize in?
Jeff Kraakivk, MD focuses on Parkinson's Disease and other conditions. In particular, much of their work with Parkinson's Disease has involved treating patients, or patients who are undergoing treatment.
Is Jeff Kraakivk, MD currently recruiting for clinical trials?
Yes, Jeff Kraakivk, MD is currently recruiting for 1 clinical trial in the USA. If you're interested in participating, you should apply.
Are there any treatments that Jeff Kraakivk, MD has studied deeply?
Yes, Jeff Kraakivk, MD has studied treatments such as Active Vibrotactile Coordinated Reset, Sham Vibrotactile Coordinated Reset.
What is the best way to schedule an appointment with Jeff Kraakivk, MD?
Apply for one of the trials that Jeff Kraakivk, MD is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.